Skip to main content

Yuan Yuan, MD, PhD, on the Approval of ORSERDU™

Yuan Yuan, MD, PhD
Medical Oncologist
Southern California

Dr Yuan, medical oncologist in Southern California, discusses key data from the EMERALD trial, the clinical relevance of ESR1 mutations, and changes in practice brought on by the approval of ORSERDU (elacestrant).

Related Articles